Vijaya Diagnostic Centre Limited has informed the Exchange regarding Resignation of Mr Ramachandra Reddy S as Chief Financial Officer of the company w.e.f. February 13, 2026.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Smallcap 250 and in line with its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre's board met on February 13, 2026 and approved several key changes. CFO Mr. S. Ramachandra Reddy stepped down from the CFO role due to organizational restructuring but continues as General Manager – Finance & Accounts. He was replaced by Mr. Ankit Shah, a Chartered Accountant with over 20 years of experience, formerly Group CFO at Incor Hospitals (OMNI Hospitals). The company also appointed a new CTO (Mr. Sai Siva Prasad, ex-Optum/UnitedHealth) and a new COO (Mr. Venkata Siva Rama Raju, ex-KIMS Hospitals and a former Vijaya employee). Two new Independent Directors — Mr. Ravi Shankararamiah (Senior Advocate) and Dr. Sasikala Paruchuri Kola (Consultant Gynaecologist) — were appointed for 5-year terms, subject to shareholder approval. The board also approved Q3 FY26 unaudited financial results, granted 1,15,000 ESOPs at ₹809 per share (20% discount), and revised its Related Party Transaction policy.
The CFO transition appears orderly and is framed as an internal restructuring, with the outgoing CFO continuing in a finance role and a seasoned external hire taking over. The simultaneous appointment of a new CTO, COO, and two independent directors suggests a strategic strengthening of the leadership team, which is generally positive for governance. Minor near-term share price volatility is possible on leadership change news, but no material disruption is indicated.